Komori
Sundrug (9989) · FactIncrease in cash flow used in financing activities during the interim period

Decrease in cash flow used in financing activities

First written in FY2026-H1. . Latest entry: FY2027-H1.

3entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2026-H1 – FY2027-H12025: 120252026: 22026
Same theme, other companies
Changes in the Direction and Fluctuations of Cash Flow from Financing ActivitiesA theme 32 companies write about · 7 as a headwind · 5 as a tailwind

The whole theme swung hardest in 2018: 2 of 18 companies on the "Worse" side.

20 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 32 companies compared. The sentences above are computed from all 32.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1Increase in cash flow used in financing activities during the interim periodAnnual report

    「Cash used in financing activities increased by ¥6.602 billion year on year to ¥9.254 billion, up 249.0% year on year. This was mainly due to factors including financing obtained in the same period of the previous year to fund capital investments for new store openings and other purposes.」

    Cash flow used in financing activities increased from ¥2.651 billion in the same period of the previous year to ¥9.254 billion. The company explained that the reversal of financing for capital investments in the same period of the previous year was the primary factor.
  2. FY2026Decrease in cash flow used in financing activities for the full fiscal yearAnnual report

    「Cash used in financing activities decreased by ¥4.946 billion from the previous fiscal year to ¥5.653 billion. This was mainly due to dividend payments and other factors.」

    Cash flow used in financing activities decreased from ¥10.6 billion in the previous fiscal year to ¥5.653 billion.
  3. FY2026-H1First statedAnnual report

    「Cash used in financing activities decreased by ¥4.596 billion year on year to ¥2.651 billion, down 63.4% year on year. This was mainly due to financing obtained to fund capital investments for new store openings and other purposes.」

    Cash flow used in financing activities decreased from ¥7.248 billion in the same period of the previous year to ¥2.651 billion. The company explained that financing obtained to fund capital investments for new store openings and other purposes was a factor.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Sundrug yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.